Embolization Coil Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

Page: 215 | Report Code: LS24101501 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

The global market value of the Embolization coil market was valued at USD 2.2 billion in 2022, and a CAGR of 8.2% is expected during the forecast period. The increasing prevalence of cardiovascular, neurological, and oncology is driving growth in the market significantly. Rising incidences of cancer and cardiovascular diseases are driving growth in the market.

According to the WHO, cardiac diseases are the main cause behind the deaths of people. Rising demand for minimally invasive procedures and increasing geriatric population all over the world are driving growth in the market significantly. Increasing demand to treat cancerous tumors at the earliest stage in life is driving growth in the market significantly.


Growth Drivers

The elderly population is more prone to uterine fibroid and liver tumors. And the rising number of elderly people all around the world is driving growth in this market significantly. Embolization coils are used to treat aneurysms and other vascular abnormalities by blocking blood flow to a targeted area. These coils are inserted into blood vessels or abnormal vascular structures through a catheter to create an artificial blockage.

The growing number of cases of cerebral aneurysms and other vascular diseases is driving growth in the market significantly. Shift towards minimally invasive surgical techniques, which offer faster recovery times and lower risks compared to traditional surgeries, has spurred demand for Embolization coils. Older adults are at high risk of vascular disorders, leading to an increased demand in the Embolization coil market.

Embolization is a less invasive alternative to traditional surgery or chemotherapy, making it a preferred treatment option for the patients who are not the candidates of more invasive surgery. The increasing number of oncology, cardiology, urology, and other chronic disease patients is driving growth in the market significantly.

Segmentation

Application

·         Neurology

·         Cardiology

·         Oncology

·         Urology

·         Peripheral Vascular Disease

Material

·         Platinum

·         Platinum and Hydrogel

·         Platinum Tungston Alloy

Type

·         Detachable Coil

·         Pushable Coil

End-Users

·         Cardiac Centers

·         Hospitals

·         Ambulatory Centers

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Embolization Coil Market by Application Segmentation

On the basis of the application, the Embolization Market is segmented into Neurology, Cardiology, Oncology, Urology, and Peripheral Vascular Disease. Oncology is the leading segment due to the rising number of geriatric people, who are more cancer-prone, especially liver, kidney, and prostate cancers, which lead to the formation of tumors that are highly vascularized, meaning they require blood flow to grow and spread.


Embolization procedures effectively block the blood flow. Embolization is a less invasive alternative to traditional surgery or chemotherapy, making it a preferred treatment option for the patients who are not the candidates of more invasive surgery. This appeal of minimal invasiveness, shorter recovery time, and fewer complications has increased the demand for Embolization in cancer treatment. Embolization allows doctors to deliver therapy directly to the tumor site, such as in trans aortic chemo Embolization.

This localized treatment minimizes the effect of the tumor. Innovations in Embolization materials have made the procedure more effective and safer for cancer treatment, encouraging its broader use in oncology. For patients with advanced stages of cancer where curative treatments are no longer an option, Embolization is often used to manage symptoms such as pain or bleeding by reducing the size of the tumor and improving the quality of life. Increasing number of cardiac patients is reason behind significant growth in cardiology segment,

 Regional Outlook

On the basis of the regions, the Embolization Coils Market is segmented into 5 types: Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. North America, particularly the United States of America, is the leading segment in the market and is expected to dominate the market during the forecast period significantly. The region has a high incidence of conditions such as cancer, neurovascular diseases, and cardiovascular diseases that necessitate Embolization procedures.

North America is home to many leading medical device companies and research institutions that focus on innovation in minimally invasive procedures. The region has a well-defined regulatory framework for medical devices, and reimbursement policies support the use of Embolization coils in various procedures. The growing elderly population in the United States of America and Canada in the region is one of the key factors behind the significant growth in the market. Asia Pacific is another leading segment in the presence of countries like Japan, China, India, and South Korea. Rising disposable income and industrialization are driving the demand in the market significantly.

Increasing urbanization in the region is the key factor driving growth in the market. The Asia-Pacific region has many countries like China and India with huge populations and a large number of geriatric populations. The incidence of conditions that need Embolization due to lifestyle changes is driving growth in the market. The region is historically underdeveloped, and reimbursement policies for advanced treatments are improving in many Asia-Pacific countries, making procedures involving Embolization coils more accessible to the general population.

Many countries in the region are implementing favorable policies to encourage the domestic production of medical devices, reduce import taxes, and streamline regulatory approvals, which boosts the local availability of Embolization coils. Countries like India, Thailand, and Singapore are becoming key hubs for medical tourism due to the low costs of treatment in comparison to western countries, which is driving growth in the market. Health professionals are being trained in minimally invasive procedures, which contributes to the higher rate of adoption of Embolization coils in treating various conditions.


The presence of many key players in the North American region is the key factor behind the significant growth. The European region is another leading segment in the market due to the growing elderly population in France, Russia, Germany, Italy, and the and the United Kingdom. The region is blessed with well-established health infrastructure. People from all over the world go to Europe for better treatment of chronic diseases like cancer and respiratory diseases. The increasing trend of minimally invasive procedures is the key reason behind the significant growth in the market. Middle East and Africa, and Latin America is witnessing slow growth in the market.

 Key Players

·         Boston Scientific Corporation

·         DePuy Synthes

·         Medtronic St. Jude Medical

·         Sirtex

·         Cook Medical

·         Cordis Corporation

·         Johnson and Johnson Services, Inc

·         Shape Memory Medical, Inc

·         Other Players

Buy Report